Pituitary Tumors

PP17-1

Long-Term Safety of Growth Hormone (GH) Replacement in Adults with GH Deficiency (GHD) Following Cure of Acromegaly – a Kims (Pfizer International Metabolic Database) Analysis
Nicholas A Tritos, Gudmundur Johannsson, Márta Korbonits, Karen K. Miller, Ulla Feldt-Rasmussen, Kevin C.J. Yuen, Donna King, Anders F. Mattsson, Peter J. Jonsson, Maria Koltowska-Haggstrom, Anne Klibanski and Beverly MK Biller

PP17-2

Phase III, Multicenter, Randomized Study (PAOLA) Demonstrating That Pasireotide LAR Has Superior Efficacy over Octreotide LAR and Lanreotide ATG in Patients with Inadequately Controlled Acromegaly
Annamaria Colao, Marcello D Bronstein, Thierry Brue, Mihail Gr Coculescu, Maria Fleseriu, Mirtha Guitelman, Vyacheslav Pronin, Gerald Raverot, Ilan Shimon, Kayo Kodama Lievre, Juergen Fleck, Mounir Aout, Alberto M Pedroncelli and Mônica Gadelha

PP17-3

PP17-4

Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly
Kadriye Aydin, Cisel Aydin, Selcuk Dagdelen, Gaye Guler Tezel and Tomris Erbas